Lung Cancer
Volume 55, Issue 1 , Pages 53-60 , January 2007

Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer

  • Niels Reinmuth

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • Clinic for Thoracic Diseases, University of Heidelberg, Amalienstr. 5, D-69126 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author at: Clinic for Thoracic Diseases, University of Heidelberg, Amalienstr. 5, D-69126 Heidelberg, Germany. Tel.: +49 6221 396 1301; fax: +49 6221 396 1302.
    • ,
  • Elisabeth Piegelbrock

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • ,
  • Miriam Raedel

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • ,
  • Nicole Fehrmann

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • ,
  • Heike Hintelmann

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • ,
  • Ruth Wagner

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • ,
  • Wolfgang E. Berdel

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • ,
  • Michael Thomas

      Affiliations

    • Clinic for Thoracic Diseases, University of Heidelberg, Amalienstr. 5, D-69126 Heidelberg, Germany
    • ,
  • Lutz Freitag

      Affiliations

    • Clinic for Pulmonary Diseases, Hemer, Germany
    • ,
  • Rolf M. Mesters

      Affiliations

    • Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany
    • IZKF Muenster, University of Muenster, Muenster, Germany

Received 14 March 2006 ,Revised 12 July 2006 ,Accepted 20 September 2006.

References 

  1. Reinmuth N, Liu W, Jung YD, et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J. 2001;15:1239–1241
  2. Kojima H, Shijubo N, Abe S. Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma. Cancer. 2002;94:1083–1093
  3. Giatromanolaki A, Koukourakis M, O’Byrne K, et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol. 1996;179:80–88
  4. Pastorino U, Andreola S, Tagliabue E, et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol. 1997;15:2858–2865
  5. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284:1994–1998
  6. Pezzella F, Pastorino U, Tagliabue E, et al. Non-small cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol. 1997;151:1417–1423
  7. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3:65–71
  8. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med. 2001;7:987–989
  9. Korff T, Kimmina S, Martiny-Baron G, et al. Blood vessel maturation in a three-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 2001;15:447–457
  10. Yang AD, Bauer TW, Camp ER, et al. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy. Cancer. 2005;103:1561–1570
  11. Tait CR, Jones PF. Angiopoietins in tumors: the angiogenic swith. J Pathol. 2004;204:1–10
  12. Hayes AJ, Huang WQ, Mallah J, et al. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res. 1999;58:224–237
  13. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998;282:468–471
  14. Ahmad SA, Liu W, Jung YD, et al. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer. 2001;92:1138–1143
  15. Chae JK, Kim I, Lim ST, et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol. 2000;20:2573–2578
  16. Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000;6:460–463
  17. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55–60
  18. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–1717
  19. Shaheen RM, Davis DW, Liu W, et al. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res. 1999;59:5412–5416
  20. Bieker R, Padro T, Kramer J, et al. Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. Cancer Res. 2003;63:7241–7246
  21. Kreuter M, Bieker R, Bielack SS, et al. Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res. 2004;10:8531–8537
  22. Reinmuth N, Fan F, Liu W, et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest. 2002;82:1377–1389
  23. Reinmuth N, Liu W, Ahmad SA, et al. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res. 2003;63:2079–2087
  24. Eberhard A, Kahlert S, Goede V, et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000;60:1388–1393
  25. Padro T, Bieker R, Ruiz S, et al. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia. 2002;16:1302–1310
  26. Offersen BV, Pfeiffer P, Hamilton-Dutoit S, et al. Patterns of angiogenesis in non-small cell lung carcinoma. Cancer. 2001;91:1500–1509
  27. Milne EN, Noonan CD, Margulis AR, et al. Vascular supply of pulmonary metastases. Experimental study in rats. Invest Radiol. 1969;4:215–229
  28. Tanaka F, Ishikawa S, Yanagihara K, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res. 2002;62:7124–7129

PII: S0169-5002(06)00516-2

doi: 10.1016/j.lungcan.2006.09.025

Lung Cancer
Volume 55, Issue 1 , Pages 53-60 , January 2007

Article Tools

* Image Usage & Resolution